Badgley, Phelps & Bell’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$483K Sell
6,208
-1,059
-15% -$78.8K 0.02% 163
2021
Q1
$535K Sell
7,267
-1,002
-12% -$73.9K 0.02% 152
2020
Q4
$645K Sell
8,269
-1,360
-14% -$104K 0.03% 142
2020
Q3
$762K Buy
9,629
+643
+7% +$50.4K 0.04% 134
2020
Q2
$663K Buy
8,986
+320
+4% +$24.1K 0.04% 132
2020
Q1
$636K Buy
8,666
+121
+1% +$9.51K 0.04% 120
2019
Q4
$742K Buy
8,545
+16
+0.2% +$1.31K 0.04% 129
2019
Q3
$685K Buy
8,529
+259
+3% +$20.8K 0.04% 126
2019
Q2
$662K Sell
8,270
-482
-6% -$36.9K 0.04% 130
2019
Q1
$695K Buy
8,752
+802
+10% +$60K 0.04% 128
2018
Q4
$580K Sell
7,950
-365
-4% -$25.8K 0.04% 129
2018
Q3
$563K Buy
8,315
+367
+5% +$23.4K 0.03% 136
2018
Q2
$460K Sell
7,948
-498
-6% -$28.1K 0.03% 144
2018
Q1
$439K Sell
8,446
-1,280
-13% -$69.1K 0.03% 143
2017
Q4
$522K Buy
9,726
+573
+6% +$31.8K 0.04% 138
2017
Q3
$559K Buy
9,153
+2,596
+40% +$157K 0.04% 121
2017
Q2
$401K Buy
6,557
+797
+14% +$48.5K 0.03% 133
2017
Q1
$349K Sell
5,760
-1,104
-16% -$67K 0.03% 132
2016
Q4
$386K Buy
6,864
+1,552
+29% +$90.8K 0.03% 130
2016
Q3
$316K Sell
5,312
-164
-3% -$9.59K 0.03% 130
2016
Q2
$301K Buy
5,476
+689
+14% +$36.7K 0.03% 131
2016
Q1
$242K Buy
+4,787
New +$234K 0.02% 138
2015
Q4
Sell
-4,846
Closed -$228K 181
2015
Q3
$228K Buy
+4,846
New +$257K 0.02% 127
2014
Q4
Sell
-3,574
Closed -$202K 176
2014
Q3
$202K Buy
+3,574
New +$201K 0.02% 134

Other funds holding MRK

Badgley, Phelps & Bell's MRK Position: Q2 2021 in Review

Badgley, Phelps & Bell reduced its Merck (MRK) stake by 15% in Q2 2021, selling an estimated $78.8K and leaving 6,208 shares worth $483K. The position accounts for 0.02% of the portfolio, ranked #163.

Badgley, Phelps & Bell first reported a position in MRK in Q3 2014 and has held it in 24 quarters since. The position peaked at $762K in Q3 2020. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Badgley, Phelps & Bell held 6,208 shares of Merck worth $483K as of Q2 2021.
  • Badgley, Phelps & Bell sold 1,059 Merck shares in Q2 2021, an estimated $78.8K.
  • Merck made up 0.02% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #163 holding.
  • Badgley, Phelps & Bell first reported a position in Merck in Q3 2014 and has held it in 24 quarters since.
  • Badgley, Phelps & Bell's Merck position peaked at $762K in Q3 2020.
  • 2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.